CN101843717B - Chinese medicament for treating coronary disease - Google Patents
Chinese medicament for treating coronary disease Download PDFInfo
- Publication number
- CN101843717B CN101843717B CN200910236179XA CN200910236179A CN101843717B CN 101843717 B CN101843717 B CN 101843717B CN 200910236179X A CN200910236179X A CN 200910236179XA CN 200910236179 A CN200910236179 A CN 200910236179A CN 101843717 B CN101843717 B CN 101843717B
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- parts
- fine powder
- heart disease
- coronary heart
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗冠心病的中药，属治疗心脑血管系统疾病的中药领域；目的是效果好，见效快；本发明采用细辛、当归、生地、桂枝、灵芝、延胡索、木通、三七等原料制成；它具有扶正培本，益气养血，活血化瘀，通阳止痛的作用，具有效果显著，药效确切，见效较快的优点。This invention relates to a traditional Chinese medicine for treating coronary heart disease, belonging to the field of traditional Chinese medicine for treating cardiovascular and cerebrovascular diseases. The aim is to achieve good and rapid effects. This invention is made from raw materials such as Asarum, Angelica sinensis, Rehmannia glutinosa, Cinnamomum cassia, Ganoderma lucidum, Corydalis yanhusuo, Akebia trifoliata, and Panax notoginseng. It has the effects of strengthening the body's resistance, nourishing qi and blood, promoting blood circulation and removing blood stasis, and relieving pain. It has the advantages of significant effects, definite efficacy, and rapid onset of action.
Description
技术领域technical field
本发明属于治疗心脑血管系统疾病的中药领域。The invention belongs to the field of traditional Chinese medicine for treating diseases of the cardiovascular and cerebrovascular systems.
背景技术Background technique
目前旨在治疗冠心病的中药领域，存在两个方面的不足：一是效果不够明显，二是见效比较迟缓。许多冠心病患者长期忍受胸闷胸痛的折磨，面临心肌梗死的危险，患者及其家属对此不够满意。At present, there are two deficiencies in the field of traditional Chinese medicine aimed at treating coronary heart disease: one is that the effect is not obvious enough, and the other is that the effect is relatively slow. Many patients with coronary heart disease suffer from chest tightness and chest pain for a long time, and face the risk of myocardial infarction. Patients and their families are not satisfied with this.
针对以上提出的问题，本发明提供一种治疗冠心病的中药，它能解决以往此类中药效果不够明显，见效比较迟缓的问题，效果好、见效快，具有效果显著，药效确切，见效较快的优点。In view of the above problems, the present invention provides a traditional Chinese medicine for the treatment of coronary heart disease, which can solve the problem that the effect of traditional Chinese medicines is not obvious enough, and the effect is relatively slow. The advantage of being fast.
发明内容Contents of the invention
本发明是通过以下技术方案来实现的：The present invention is achieved through the following technical solutions:
一种治疗冠心病的中药，采用中药原料制备，配方为(按重量比)：A kind of Chinese medicine for treating coronary heart disease, adopts Chinese medicine raw material to prepare, and formula is (by weight):
细辛2-15份 当归4-30份 生地4-30份Asarum 2-15 parts Angelica 4-30 parts Raw land 4-30 parts
桂枝3-20份 灵芝2-15份 延胡索3-20份Guizhi 3-20 parts Ganoderma lucidum 2-15 parts Corydalis 3-20 parts
木通3-20份 三七3-20份Akebia 3-20 copies Sanqi 3-20 copies
这种治疗冠心病的中药是由下列方法制成的：This traditional Chinese medicine for treating coronary heart disease is made by the following methods:
(1)按上述重量比，将细辛、当归、生地、桂枝、延胡索、木通经常规水提取工艺提取，制成浸膏细粉；(1) According to the above weight ratio, Asarum, Angelica, Radix Rehmanniae, Guizhi, Corydalis Corydalis, Akebiae are extracted through a conventional water extraction process to make extract powder;
(2)按上述重量比，将灵芝、三七分别研成细粉，与上述浸膏细粉混合，搅拌均匀；根据需要，可制成中药冲剂、颗粒剂、散剂、胶囊剂、水丸剂、片剂等剂型。(2) According to the above weight ratio, grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, mix with the above-mentioned extract powder, and stir evenly; as required, it can be made into Chinese medicine granules, granules, powders, capsules, water pills, Dosage forms such as tablets.
本发明是根据民间传统配方，根据中医扶正培本、活血化瘀的理论，精心研制而成。方中灵芝、生地益气养血，扶正培本；桂枝、细辛温散寒邪，通阳止痛；当归、三七活血化瘀止痛；辅以木通入经通络，加延胡索活血、理气、止痛。诸药配伍，相得益彰，共奏扶正培本，益气养血，活血化瘀，通阳止痛之功，效果好，见效快，具有效果显著，药效确切，见效较快的优点。The present invention is elaborately developed according to the folk traditional formula and the theory of traditional Chinese medicine of strengthening the body and strengthening the body, promoting blood circulation and removing blood stasis. In the prescription, Ganoderma lucidum and Shengdi nourish qi and blood, and strengthen the body; Guizhi and Asarum warm and dispel cold pathogens, unblock yang and relieve pain; Regulate qi and relieve pain. All the medicines are compatible and complement each other, and play the functions of strengthening the body, nourishing qi and nourishing blood, promoting blood circulation and removing blood stasis, promoting yang and relieving pain. The effect is good, and the effect is fast.
具体实施方式Detailed ways
通过以下实施方式对本发明做具体说明：The present invention is specifically described by the following embodiments:
1、取以下配方(重量按克为单位)：1. Take the following formula (weight is in grams):
细辛30克 当归70克 生地70克30 grams of asarum, 70 grams of angelica, 70 grams of raw ground
桂枝50克 灵芝30克 延胡索50克Guizhi 50g Ganoderma lucidum 30g Corydalis 50g
木通50克 三七50克Akebia 50g Sanqi 50g
按规定重量，用常规水提取工艺将细辛、当归、生地、桂枝、延胡索、木通提取，制成浸膏细粉96克，将灵芝、三七分别研成细粉，与上述浸膏细粉混合，搅拌均匀，制成细小颗粒，装入0号胶囊，制成中药胶囊628粒，每粒胶囊内含中药细粉及提取物0.28克。According to the specified weight, extract Asarum, Angelica, Rehmannia, Guizhi, Corydalis, and Akebia with conventional water extraction process to make 96 grams of extract powder, grind Ganoderma lucidum and Panax notoginseng into fine powder respectively, and mix with the above extract The fine powder is mixed, stirred evenly, made into fine particles, packed into No. 0 capsules, and made into 628 Chinese medicine capsules, each capsule containing 0.28 grams of Chinese medicine fine powder and extract.
2、取以下配方(重量按克为单位)：2. Take the following formula (weight is in grams):
细辛70克 当归150克 生地150克Asarum 70g Angelica 150g Raw Ground 150g
桂枝100克 灵芝70克 延胡索150克Guizhi 100g Ganoderma lucidum 70g Corydalis 150g
木通100克 三七150克Akebia 100g Sanqi 150g
按上述同样的方法，制成中药胶囊1557粒，每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 1557 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.
3、取以下配方(重量按克为单位)：3. Take the following formula (the weight is in grams):
细辛150克 当归300克 生地300克Asarum 150g Angelica 300g Raw Ground 300g
桂枝200克 灵芝150克 延胡索200克Guizhi 200g Ganoderma lucidum 150g Corydalis 200g
木通200克 三七200克Akebia 200g Sanqi 200g
按上述同样的方法，制成中药胶囊2696粒，每粒胶囊内含中药细粉及提取物0.28克。By above-mentioned same method, make 2696 Chinese medicine capsules, every capsule contains Chinese medicine fine powder and extract 0.28 gram.
4、取以下配方(按重量比)：4. Take the following formula (by weight):
细辛4份 当归7份 生地7份Asarum 4 parts Angelica 7 parts Rehmannia 7 parts
桂枝6份 灵芝4份 延胡索6份Guizhi 6 parts Ganoderma lucidum 4 parts Corydalis 6 parts
木通6份 三七5份Akebia 6 parts Panax notoginseng 5 parts
按上述同样的方法，制成中药胶囊，每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.
5、取以下配方(按重量比)：5. Take the following formula (by weight):
细辛12份 当归25份 生地25份Asarum 12 parts Angelica 25 parts Rehmannia 25 parts
桂枝18份 灵芝12份 延胡索18份Guizhi 18 parts Ganoderma lucidum 12 parts Corydalis 18 parts
木通18份 三七18份Akebia 18 parts Panax notoginseng 18 parts
按上述同样的方法，制成中药胶囊，每粒胶囊内含中药细粉及提取物0.28克。By the above-mentioned same method, Chinese medicine capsules are made, and each capsule contains 0.28 grams of Chinese medicine fine powder and extract.
临床资料：clinical information:
本发明以中医冠心病为例，经11例临床观察。选择中医诊断冠心病为标准：体质虚弱，肢软乏力，胸闷胸痛，头晕心慌，心电图检查心肌缺血。如上症状，即可确诊。在确诊观察的对象中，男性6例，女性5例，无其它严重疾病，年龄为42岁-76岁，平均年龄57.1岁。The present invention takes coronary heart disease of traditional Chinese medicine as an example, through clinical observation of 11 cases. TCM diagnosis of coronary heart disease was selected as the standard: physical weakness, limb weakness, chest tightness and chest pain, dizziness and palpitation, and myocardial ischemia by electrocardiogram. The above symptoms can be diagnosed. Among the objects under confirmed observation, there were 6 males and 5 females, without other serious diseases, aged from 42 to 76 years old, with an average age of 57.1 years.
疗效判定：Judgment of curative effect:
1、显效：体质增强，身上有劲，胸闷胸痛等心区不适明显缓解，心电图可见心肌供血明显改善。1. Significant effect: Physical fitness is enhanced, body is strong, chest pain and other discomfort in the heart area are significantly relieved, and the electrocardiogram shows that the blood supply to the myocardium is significantly improved.
2、有效：体质增强，胸闷胸痛等心区不适有所缓解。2. Effective: Physical fitness is enhanced, and discomfort in the heart area such as chest tightness and chest pain is relieved.
3、无效：病症无变化。3. Ineffective: no change in symptoms.
临床实验时，停服其它药物和保健营养品。服用本发明中药胶囊，观察3个月，为一个疗程。服用方法：每日3次，每次4粒胶囊，每粒胶囊内含中药细粉及提取物0.28克，饭后温开水送服，30天后症状即有缓解，服用3个月后，症状明显改善。临床实验的11人中，显效5人，有效5人，无效1人，总有效率91.6％。During the clinical trial, stop taking other medicines and health nutrition products. Take Chinese medicine capsule of the present invention, observe 3 months, be a course of treatment. Dosing method: 3 times a day, 4 capsules each time, each capsule contains 0.28g of fine powder and extract of traditional Chinese medicine, take it with warm water after meals, the symptoms will be relieved after 30 days, and the symptoms will be obvious after taking it for 3 months improve. Among the 11 people in the clinical trial, 5 people were markedly effective, 5 people were effective, and 1 person was ineffective, and the total effective rate was 91.6%.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910236179XA CN101843717B (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating coronary disease |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200910236179XA CN101843717B (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating coronary disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843717A CN101843717A (en) | 2010-09-29 |
| CN101843717B true CN101843717B (en) | 2011-09-28 |
Family
ID=42768653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN200910236179XA Expired - Fee Related CN101843717B (en) | 2009-10-22 | 2009-10-22 | Chinese medicament for treating coronary disease |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843717B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102091247B (en) * | 2010-12-06 | 2012-01-11 | 熊攀 | Traditional Chinese medicine composition for treating coronary heart disease |
-
2009
- 2009-10-22 CN CN200910236179XA patent/CN101843717B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843717A (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843699A (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843723B (en) | Chinese medicament for treating abnormal menstruation | |
| CN101843712B (en) | Chinese medicament for treating angina | |
| CN101843660B (en) | Chinese medicament for treating tachycardia | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101530479B (en) | Traditional Chinese medicine for treating diabetes mellitus and muscle atrophy | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843753B (en) | Chinese medicament for treating angina | |
| CN101843717A (en) | Chinese medicament for treating coronary disease | |
| CN101850015B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843807A (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101537121A (en) | Chinese medicine for treating arteriosclerosis | |
| CN101843835B (en) | Chinese medicament for treating coronary diseases | |
| CN101843756B (en) | Chinese medicament for treating chronic nephritis | |
| CN101879259B (en) | Traditional Chinese medicine for treating pulmonary heart diseases | |
| CN101843831B (en) | Chinese medicament for treating diabetic cardiopathy | |
| CN101843700A (en) | Chinese medicament for treating coronary disease | |
| CN101843870B (en) | Chinese medicament for treating diabetic acro-necrosis | |
| CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843745B (en) | Chinese medicament for treating chronic hepatitis | |
| CN101843673B (en) | Chinese medicament for treating arteriosclerosis | |
| CN101843696A (en) | Chinese medicament for treating diabetic nephropathy | |
| CN101843796A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843730A (en) | Chinese medicament for treating coronary disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: RUGAO RICH STEEL MACHINERY PARTS CO., LTD. Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20130710 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 226500 NANTONG, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20130710 Address after: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups Patentee after: Rugao Fu Steel Machinery Fittings Co., Ltd. Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CB03 | Change of inventor or designer information |
Inventor after: Deng Wenrong Inventor before: Liu Xinzhuang |
|
| CB03 | Change of inventor or designer information | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20171229 Address after: Dacheng County, Hebei province 065999 Langfang City Ping Shu Zhen Nan Huan Xi Lu IFAD No. 1 Building 2 unit 301 room Patentee after: Deng Wenrong Address before: 226500, Jiangsu, Rugao moved by the town, moved through the village of twenty-four groups Patentee before: Rugao Fu Steel Machinery Fittings Co., Ltd. |
|
| TR01 | Transfer of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110928 Termination date: 20181022 |